L627-1088 Screening compound: N-[(3,4-dimethylphenyl)methyl]-4-{[1-methyl-3-(pyrrolidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]methyl}benzamide

L627-1088 Screening compound: N-[(3,4-dimethylphenyl)methyl]-4-{[1-methyl-3-(pyrrolidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]methyl}benzamide
L627-1088 Screening compound: N-[(3,4-dimethylphenyl)methyl]-4-{[1-methyl-3-(pyrrolidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]methyl}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L627-1088
N-[(3,4-dimethylphenyl)methyl]-4-{[1-methyl-3-(pyrrolidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]methyl}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L627-1088

Molecular Formula

C29H35N5O2 (C29 H35 N5 O2)

Compound Name

N-[(3,4-dimethylphenyl)methyl]-4-{[1-methyl-3-(pyrrolidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]methyl}benzamide

IUPAC name

N-[(34-dimethylphenyl)methyl]-4-{[1-methyl-3-(pyrrolidine-1-carbonyl)-1H4H5H6H7H-pyrazolo[43-c]pyridin-5-yl]methyl}benzamide

SMILES

Cc1c(C)cc(CNC(c2ccc(CN(CC3)Cc4c3n(C)nc4C(N3CCCC3)=O)cc2)=O)cc1

InChI

InChI=1S/C29H35N5O2/c1-20-6-7-23(16-21(20)2)17-30-28(35)24-10-8-22(9-11-24)18-33-15-12-26-25(19-33)27(31-32(26)3)29(36)34-13-4-5-14-34/h6-11,16H,4-5,12-15,17-19H2,1-3H3,(H,30,35)

InChI Key

SABRZDPYBJUDRR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27466130

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

485.63

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.291

Distribution Coefficient, logD

-3.028

Water Solubility, LogSw

-3.48

Polar Surface Area

60.078

Acid Dissociation Constant (pKa)

11.60

Base Dissociation Constant (pKb)

13.72

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

41.40

L627-1088 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Cysteine Proteases Inhibitors Library (7839 compounds)

Hsp90-Targeted Library (11355 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Ion Channels Focused Library (26372 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Nervous system
  • Cardiovascular
Targets:
  • Proteases
  • Kinases
  • Ion Channels

References: we are preparing a list of scientific research reports with L627-1088 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L627-1088?
Check Price and Availability of L627-1088, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L627-1088 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L627-1088
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L627-1088
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L627-1088 available by request